BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«UCB S.A.

Below is an extended UCB S.A. news listing. Click here to return to the UCB S.A. main Biocorporate entry.

BioNews Results for UCB S.A.:

DIARY - Western European Corporate events from Oct 30, 2008
Sharewatch:  Oct 30 2008 5:51AM Matching: ucb s
UCB's Vimpat Approved By U.S. FDA As Adjunctive Therapy for Partial Onset Seizures in Adults
Pharma Live:  Oct 29 2008 3:48PM Matching: ucb s

«UCB S.A.

This page contained an extended UCB S.A. news listing. Click here to return to the UCB S.A. main Biocorporate entry.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.